ALNYLAM PHARMACEUTICALS, INC. — Director's Dealing 2012

Feb 23, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK: 0001178670
Period of Report: 2012-02-21

Reporting Person: SHARP PHILIP A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-21	Common Stock	P	9302	$10.75	Acquired	9302	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	252630	Indirect

Footnotes

F1: The purchase reported on this Form 4 was made by the reporting person in connection with the Company's Public Offering of Common Stock.